Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Aging & Longevity

Sleep Drinks Go Mainstream as Wellness Brands Monetize America’s Sleep Deficit

by Team Lumida
December 30, 2025
in Aging & Longevity
Reading Time: 3 mins read
A A
0
Sleep Drinks Go Mainstream as Wellness Brands Monetize America’s Sleep Deficit
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways
Powered by lumidawealth.com

  • Sleep-aid beverages are a fast-growing wellness category, with supplement sales nearing $1B in 2025.
  • Social-media trends and sleep-tracking devices are accelerating consumer adoption.
  • Scientific evidence on effectiveness is mixed, raising questions about durability and regulation.
  • The category is attracting premium pricing, strong branding, and celebrity-driven demand.

What Happened?

A new class of sleep-focused beverages—powdered mixes and ready-to-drink nightcaps containing ingredients like magnesium, L-theanine, and herbs—has gained rapid traction. Roughly 22% of U.S. adults now report consuming drinks that claim to improve sleep, up sharply from a year earlier. Sales of sleep supplements rose 6.4% in 2025 to about $1 billion, while ready-to-drink sleep beverages also posted strong growth. Brands such as Som Sleep, MoonBrew, Dream Water, and AG1’s new sleep product AGZ are expanding distribution, leaning on subscriptions, premium pricing, and lifestyle branding.

Why It Matters?

Poor sleep is widespread, creating a large and recurring consumer market. The category sits at the intersection of wellness, functional beverages, and supplements—segments with high margins and strong customer loyalty. For investors, the opportunity lies less in proven medical efficacy and more in branding, habit formation, and perceived benefits, similar to prior waves in probiotics, greens powders, and CBD. However, mixed scientific evidence and potential regulatory scrutiny pose long-term risks, especially if health claims come under tighter oversight.

What’s Next?

Growth is likely to continue as sleep tracking becomes more mainstream and consumers seek non-pharmaceutical solutions. Competition will intensify, pushing brands to differentiate through taste, ritual, and clean-label positioning rather than clinical proof. Investors should watch for consolidation, retailer pushback on premium pricing, and any regulatory shifts around supplement claims that could reshape the category’s economics.

Source
Previous Post

U.S. Leads the AI Race—for Now—as Chip Policy Shift Gives China New Momentum

Next Post

Citi Exits Russia at a Cost, Booking $1.1B Loss to Close a Decade-Long Retreat

Recommended For You

Nike CEO Secures NFL Partnership Through 2038, Signaling Return to Sports-First Strategy

by Team Lumida
11 months ago
white and black concrete building

Key Takeaways: Powered by lumidawealth.com Nike extends NFL licensing deal through 2038, maintaining crucial partnership for on-field uniforms New agreement focuses on international expansion and grassroots development Partnership includes...

Read more

Fine Wine Market Faces Second Year of Decline as Chinese Demand Evaporates

by Team Lumida
1 year ago
hanging meat near bar counter

Key Takeaways: Powered by lumidawealth.com• Liv-ex Fine Wine 100 index down 9.2% YTD while global stocks up 20%• Premium wines see dramatic price drops (some Burgundies down 44%)• Chinese...

Read more

Study Links Taxi Driving to Lower Alzheimer’s Risk, Highlighting Brain-Protective Activities

by Team Lumida
1 year ago
orange and black round light

Key Takeaways: Powered by lumidawealth.com Taxi and ambulance drivers show lowest Alzheimer's death rates among 400+ occupations Only 1.03% of taxi drivers died from Alzheimer's vs. 3.9% general population...

Read more

Agricultural Downturn: U.S. Farm Sector Faces Recession Amid Price Drops and Rising Costs

by Team Lumida
1 year ago
silhouette of man riding tractor

Key Takeaways: Powered by lumidawealth.com• Net farm income declined 4% in 2024 after a 20% drop in 2023• $10 billion federal support package approved for farmers, plus $21 billion...

Read more

Age and Inflammation: The Unseen Health Hazard

by Team Lumida
1 year ago
Age and Inflammation: The Unseen Health Hazard

Researchers have highlighted a growing health concern: inflammaging.

Read more

Exclusive Insights into the Elite: An Escort’s Perspective

by Team Lumida
1 year ago
man in black long sleeve shirt smoking

An ex-escort shared her experiences working for the 1%, highlighting the significant gap between public perception and reality.

Read more

Google’s Bold AI Bet: Transforming Healthcare After Costly Missteps

by Team Lumida
1 year ago
Google’s Bold AI Bet: Transforming Healthcare After Costly Missteps

Google is making a significant push to revitalize its healthcare ventures by integrating advanced artificial intelligence (AI) technologies.

Read more

Rising Influence of Older Voters: How Retirees Shape Western Politics

by Team Lumida
2 years ago
family, grandma, grandmother

Older voters are becoming a decisive force in elections across the U.S., U.K., and France.

Read more

Falling Birth Rates in Wealthy Nations: Economic Growth at Risk

by Team Lumida
2 years ago
A baby's feet.

Birth rates in OECD countries dropped from 3.3 in 1960 to 1.5 in 2022, posing threats to economic growth and labor force stability. Policies supporting gender equality and...

Read more

Netflix Binge-Watching Linked to Shorter Lifespan: Here’s How to Mitigate the Risk

by Team Lumida
2 years ago
black flat screen tv turned on displaying 11

New research from the Nurses’ Health Study, published in JAMA Network, reveals that spending more time watching TV is linked to less healthy aging.

Read more
Next Post
Citigroup Q2 2024 Earnings Summary

Citi Exits Russia at a Cost, Booking $1.1B Loss to Close a Decade-Long Retreat

Trump Suggests $2,000 Tariff-Funded Payouts to Americans

Trump Reignites Fed Independence Fears as Powell Firing Talk Returns

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

smiling woman in gray cardigan

High Earners 50+ Lose Pretax 401(k) Catch‑Up

September 24, 2025
SEC Offers Relief for IPOs Stuck in Limbo During Shutdown

SEC Offers Relief for IPOs Stuck in Limbo During Shutdown

October 10, 2025
Crypto Panic: Bitcoin Crashes to $53K, Ether Faces 2024 Downturn

Crypto Panic: Bitcoin Crashes to $53K, Ether Faces 2024 Downturn

August 5, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018